Literature DB >> 12759378

Potential pitfalls in the use of surrogate endpoints in colorectal adenoma chemoprevention.

Bernard Levin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759378     DOI: 10.1093/jnci/95.10.697

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Of timing and surrogates: a way forward for cancer chemoprevention.

Authors:  Patricia A Thompson; Eugene W Gerner
Journal:  Clin Cancer Res       Date:  2011-04-15       Impact factor: 12.531

2.  Rationale and design of the European Polyp Surveillance (EPoS) trials.

Authors:  Rodrigo Jover; Michael Bretthauer; Evelien Dekker; Øyvind Holme; Michal F Kaminski; Magnus Løberg; Ann G Zauber; Miguel A Hernán; Iris Lansdorp-Vogelaar; Annike Sunde; Eleanor McFadden; Antoni Castells; Jaroslaw Regula; Enrique Quintero; Maria Pellisé; Carlo Senore; Mette Kalager; Mario Dinis-Ribeiro; Louise Emilsson; David F Ransohoff; Geir Hoff; Hans-Olov Adami
Journal:  Endoscopy       Date:  2016-04-04       Impact factor: 10.093

3.  Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials.

Authors:  Sajesh K Veettil; Nattawat Teerawattanapong; Siew Mooi Ching; Kean Ghee Lim; Surasak Saokaew; Pochamana Phisalprapa; Nathorn Chaiyakunapruk
Journal:  Onco Targets Ther       Date:  2017-05-23       Impact factor: 4.147

Review 4.  Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials.

Authors:  Sajesh K Veettil; Kean Ghee Lim; Siew Mooi Ching; Surasak Saokaew; Pochamana Phisalprapa; Nathorn Chaiyakunapruk
Journal:  BMC Cancer       Date:  2017-11-14       Impact factor: 4.430

5.  A perfect correlate does not a surrogate make.

Authors:  Stuart G Baker; Barnett S Kramer
Journal:  BMC Med Res Methodol       Date:  2003-09-09       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.